{"effective_time":"20201104","id":"e3eb88a5-c63e-4bb7-b062-461a1778150a","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 1.8 mL Vial Label PAA156051 LOT/EXP Pfizer-BioNTech COVID-19 Vaccine After dilution, vial contains 5 doses of 0.3 mL For intramuscular use. Contains no preservative. For use under Emergency Use Authorization. DILUTE BEFORE USE. Discard 6 hours after dilution when stored at 2 to 25°C (35 to 77°F). Dilution date and time: NDC 59267-1000-1 Principal Display Panel - 1.8 mL Vial Label","PRINCIPAL DISPLAY PANEL - 195 Vial Carton NDC 59267-1000-2 Pfizer-BioNTech COVID-19 Vaccine Suspension for Intramuscular Injection 195 Multiple Dose Vials (after dilution each vial contains 5 doses of 0.3 mL) Pfizer | BIONTECH STORAGE: Prior to dilution, store at -80°C to -60°C (-112°F to -76°F). Store in this carton to protect from light. DOSAGE AND ADMINISTRATION: After dilution, each vial contains 5 doses of 0.3 mL. See FDA-authorized Fact Sheet or scan QR code for information. MUST BE DILUTED BEFORE USE with sterile 0.9% Sodium Chloride Injection, USP (not supplied). After dilution, store the vaccine at 2°C to 25°C (35°F to 77°F). Discard after 6 hours. Contains no preservative. For use under Emergency Use Authorization. Rx only Manufactured by Pfizer Inc New York, NY 10017 Manufactured for BioNTech Manufacturing GmbH An der Goldgrube 12 55131 Mainz, Germany PAA156052 LOT: EXP: Principal Display Panel - 195 Vial Carton"],"set_id":"908ecbe7-2f1b-42dd-94bf-f917ec3c5af8","spl_product_data_elements":["Pfizer-BioNTech Covid-19 Vaccine RNA ingredient BNT-162B2 RNA ingredient BNT-162B2 RNA ingredient BNT-162B2 lipid ALC-0159 lipid ALC-0315 POTASSIUM CHLORIDE MONOBASIC POTASSIUM PHOSPHATE SODIUM CHLORIDE SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM SUCROSE"],"version":"1"}